UCSF 42nd Annual Advances in Heart Disease 2025

 🧑🏾‍💻 👩🏼‍💻 Target Audience

This course is designed for a broad range of healthcare professionals involved in cardiovascular care, including:

• Cardiovascular specialists

• Practicing cardiologists

• Internists and family physicians

• Cardiovascular and critical care nurses

• Physician assistants

💯 Learning Objectives

Upon completion of this course, participants will be better able to enhance their clinical skills and strategies to:

• Provide optimal management of:

  • Coronary heart disease

  • Hypertension

  • Lipid disorders

  • Diabetes

  • Systolic and diastolic heart failure

  • Atrial fibrillation

  • STEMI and non-STEMI

  • Thromboembolic disease

• Refine clinical decision-making for:

  • Atrial fibrillation, atrial flutter, and ventricular tachycardia ablation

• Apply best practices for:

  • Percutaneous coronary interventions

  • Percutaneous treatment of valvular heart disease

• Optimize the use of:

  • Antiplatelet therapy

  • Anticoagulation therapy in cardiovascular disease

• Recognize and apply cardiovascular risk stratification strategies

• Understand how social determinants of health impact cardiovascular disease pathophysiology and treatment outcomes

• Implement strategies to improve cardiovascular health outcomes across diverse patient populations

 📌 Course Outline

Friday, December 12, 2025

7:50 AM – Course Webinar Opens

8:00 AM – Welcome and Symposium Overview
Peter Ganz, MD, FACC

Session: Frontiers in Interventional Cardiology

Chair: Lucas Zier, MD, MS

• 8:05 AM – Proactive Management of Severe Aortic Stenosis: From Detection to Early Treatment
  Sammy Elmariah, MD, MPH, FACC

• 8:45 AM – Updates on the Management of Mitral and Tricuspid Valve Disease
  Michela Faggioni, MD, FACC

• 9:25 AM – A New Perspective on Old Therapies for Myocardial Infarction: Beta Blockers and Spironolactone
  Krishan Soni, MD, MBA, FACC

• 10:05 AM – Coffee Break

• 10:20 AM – Review of Treatment Guidelines for Acute Coronary Syndromes
  John MacGregor, MD, PhD, FACC

• 11:00 AM – Renal Denervation Therapy for Resistant Hypertension
  Joseph Yang, MD, FACC

• 11:40 AM – Updates on Chronic Total Occlusions and Complete Revascularization
  Yousif Ahmad, MBBS, PhD

• 12:20 PM – Lunch (Optional Product Theater)

Session: Advances in Cardiovascular Disease Management and Prevention

Chair: Peter Ganz, MD

• 1:50 PM – Cardiovascular-Kidney-Metabolic (CKM) Syndrome
  Chiadi E. Ndumele, MD, PhD

• 2:30 PM – Elliot Rapaport, MD Keynote Lecture:
  Pulmonary Embolism – Historical Perspective and Glimpses into the Future
  Samuel Z. Goldhaber, MD

• 3:15 PM – Update on the Management of Hypertension: 2025 AHA/ACC Guidelines
  Mary Gray, MD

• 3:55 PM – Coffee Break

• 4:10 PM – Update on Cardiovascular Complications of Cancer Treatments
  Javid Moslehi, MD

• 4:50 PM – Contemporary Pulmonary Hypertension Management
  Marc Simon, MD, MS, FACC

• 5:30 PM – Adjourn

Saturday, December 13, 2025

7:30 AM – Continental Breakfast
7:50 AM – Course Webinar Opens
8:00 AM – Announcements
Peter Ganz, MD

Session: Advances and Controversies in Electrophysiology

Chair: Nora Goldschlager, MD, FACC

• 8:05 AM – Leadless vs. Leaded Pacemakers: Which One for Which Patient?
  Adam Oesterle, MD

• 8:45 AM – When to Anticoagulate Device-Detected Atrial Fibrillation: Latest Evidence
  Joshua Moss, MD, MS, FACC

• 9:25 AM – Premature Atrial Contractions and Atrial Fibrillation: Association or Causation?
  Edward Gerstenfeld, MD, MS, FACC

• 10:05 AM – Coffee Break

• 10:20 AM – Which ICD Is Best for My Patient: Transvenous, S-ICD, or EV-ICD?
  Daniel Morin, MD, MPH

• 11:00 AM – Atrial Fibrillation and Stroke Prevention: Current Evidence and Future Directions
  Cara Pellegrini, MD

• 11:40 AM – Lifestyle and Atrial Fibrillation: Conventional Wisdom versus the Evidence
  Gregory Marcus, MD, MAS, FACC

• 12:20 PM – Lunch (Optional Product Theater)

Session: Advances and Controversies in Electrophysiology (Continued)

Chair: Nora Goldschlager, MD, FACC

• 1:20 PM – How to Evaluate Family Members of Sudden Cardiac Arrest Victims
  Albert Liu, MD

Session: Advances in Heart Failure

Chair: Jonathan Davis, MD, MPH

• 1:50 PM – The Expanding Role of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Heart Failure and Beyond
  Carlos Santos-Gallego, MD

• 2:30 PM – Contemporary Approaches to Identifying, Classifying, and Treating Cardiogenic Shock
  Christopher Barnett, MD, MHP, FACC

• 3:10 PM – Coffee Break

• 3:25 PM – What’s Coming Down the Pipeline for Heart Failure
  Liviu Klein, MD, MS

• 4:05 PM – Finerenone vs. Spironolactone: The Role of Non-Steroidal MRAs in Contemporary Practice
  Shweta Motiwala, MD, MPH, FACC

• 4:45 PM – Adjourn

Sunday, December 14, 2025

7:30 AM – Continental Breakfast
8:00 AM – Announcements
Peter Ganz, MD

Session: Advances in Managing Cardiovascular Diseases

Chair: Mary Gray, MD

• 8:05 AM – Updates in Pericarditis: From Pathophysiology to Clinical Practice
  Alan Baik, MD, PhD

• 8:45 AM – Management of Cardiovascular Disease in Patients with Kidney Failure Undergoing Maintenance Dialysis
  Ruth Dubin, MD

• 9:25 AM – Managing Cardiovascular Disease in Pregnancy
  Aarthi Sabanayagam, MD, MBBS, FACC

• 10:05 AM – Iron Deficiency: A Key Target in Heart Failure Management
  Pooja Prasad, MD

• 10:45 AM – Use of Artificial Intelligence and Machine Learning to Improve Cardiovascular Outcomes
  Lucas Zier, MD, MS

• 11:25 AM – Inflammation in the Detection and Treatment of Atherosclerotic Disease
  Paul M. Ridker, MD, MPH

• 12:05 PM – Adjourn